Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India

par Ajay Gogia, Sukesh Nair, Shalabh Arora, Lalit Kumar, Atul Sharma, Ritu Gupta, Ahitagni Biswas, Saumyaranjan Mallick
Publié 2021

Proteomic Profiling Differentiates Lymphoma Patients with and without Concurrent Myeloproliferative Neoplasia

par Johanne Marie Holst, Marie Beck Enemark, Martin Bjerregaard Pedersen, Kristina Lystlund Lauridsen, Trine Engelbrecht Hybel, Michael Roost Clausen, Henrik Frederiksen, Michael Boe Møller, Peter Nørgaard, Trine Lindhardt Plesner, Stephen Jacques Hamilton-Dutoit, Francesco d’Amore, Bent Honoré, Maja Ludvigsen
Publié 2021

CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL)

par Guido Gini, Alice Di Rocco, Luca Nassi, Annalisa Arcari, Maria Chiara Tisi, Giacomo Loseto, Attilio Olivieri, Massimo Gentile, Ombretta Annibali, Maria Giuseppina Cabras, Annalisa Chiappella, Chiara Rusconi, Andrés José María Ferreri, Monica Balzarotti
Publié 2021

ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma

par Giulio Sartori, Sara Napoli, Luciano Cascione, Elaine Yee Lin Chung, Valdemar Priebe, Alberto Jesus Arribas, Afua Adjeiwaa Mensah, Michela Dall’Angelo, Chiara Falzarano, Laura Barnabei, Mattia Forcato, Andrea Rinaldi, Silvio Bicciato, Margot Thome, Francesco Bertoni
Publié 2021

Efficacy and Safety of Innovative Experimental Chimeric Antigen Receptor (CAR) T-cells versus Axicabtagene ciloleucel (Yescarta) for the Treatment of Relapsed/Refractory Large B-Ce...

par Bayarmagnai Weinstein, Bogdan Muresan, Sara Solano, Antonio Vaz de Macedo, YoonJung Lee, Yu-Chen Su, Yeseul Ahn, Gabriela Henriquez, Christina Carmago, Gwang-Jin Kim, David O. Carpenter
Publié 2021

Immunotherapy for Diffuse Large B-Cell Lymphoma: Current Landscape and Future Directions

par Dipenkumar Modi, Bindu Potugari, Joseph Uberti
Publié 2021

High Ki67 proliferation index but not cell-of-origin subtypes is associated with shorter overall survival in diffuse large B-cell lymphoma

par Feras Zaiem, Rada Jerbi, Omar Albanyan, Jordyn Puccio, Zyad Kafri, Jay Yang, Ali M Gabali
Publié 2020